Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 3 , Pages 195-200 , May 2006

Antiprostasome antibodies: Possible serum markers for prostate cancer metastasizing liability

  • Anders Larsson, Prof.

      Affiliations

    • Department of Medical Sciences, Clinical Chemistry, University Hospital, Uppsala, Uppsala, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46-18-6110000; fax: +46-18-552562.
  • ,
  • Gunnar Ronquist, Prof.

      Affiliations

    • Department of Medical Sciences, Clinical Chemistry, University Hospital, Uppsala, Uppsala, Sweden
  • ,
  • Christian Wülfing, M.D.

      Affiliations

    • Department of Urology–Prostate Center, University Clinic, Münster, Germany
  • ,
  • Elke Eltze, M.D.

      Affiliations

    • Institute of Pathology, University Clinic, Münster, Germany
  • ,
  • Olaf Bettendorf, M.D.

      Affiliations

    • Institute of Pathology, University Clinic, Münster, Germany
  • ,
  • Lena Carlsson, Ph.D.

      Affiliations

    • Department of Medical Sciences, Clinical Chemistry, University Hospital, Uppsala, Uppsala, Sweden
  • ,
  • B. Ove Nilsson, Prof.

      Affiliations

    • Department of Medical Cell Biology, Biomedical Center, Uppsala, Sweden
  • ,
  • Axel Semjonow, M.D.

      Affiliations

    • Department of Urology–Prostate Center, University Clinic, Münster, Germany

Received 17 March 2005 ,Revised 8 July 2005 ,Accepted 9 July 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by the Swedish Research Council and Lions Cancer Foundation.

PII: S1078-1439(05)00202-4

doi: 10.1016/j.urolonc.2005.07.009

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 3 , Pages 195-200 , May 2006